Tag: Casirivimab/imdevimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Casirivimab/imdevimab

COVID drugs more often given to Medicare patients who least need them, study suggests

Added to Collection on: 2024-01-26 21:57:52

Tags for this article:

COVID-19 drug development
Treatment and management of COVID-19
Nirmatrelvir/ritonavir
Bamlanivimab
Casirivimab/imdevimab
Sotrovimab
Molnupiravir
Remdesivir
Nirmatrelvir
COVID-19
COVID-19 drug repurposing research
Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details
After slow start, demand for COVID monoclonal antibodies treatment skyrockets

Added to Collection on: 2024-04-01 17:33:34

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Immunology
Immune system
Antiviral drugs
Regeneron Pharmaceuticals
Casirivimab/imdevimab
Sotrovimab
Antibody
COVID-19 pandemic
Bamlanivimab
Anti-immunoglobulin
Donald Trump

Click the tags to see associated articles and topics

View Article Details
Pemgarda Granted EUA to Prevent COVID-19, Now Available in US - Drug Topics

Added to Collection on: 2024-04-30 20:38:35

Tags for this article:

COVID-19 drug development
COVID-19 vaccination in the United States
RNA vaccines
Monoclonal antibodies
Pre-exposure prophylaxis
COVID-19
Variants of SARS-CoV-2
Pfizer-BioNTech COVID-19 vaccine
Moderna COVID-19 vaccine
Tixagevimab/cilgavimab
Casirivimab/imdevimab

Click the tags to see associated articles and topics

View Article Details
FDA Revokes EUAs of Four COVID-19 Monoclonal Antibodies - MedPage Today

Added to Collection on: 2024-12-13 22:37:09

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Antiviral drugs
Casirivimab/imdevimab
Immune system
Tixagevimab/cilgavimab
Sotrovimab
Bebtelovimab
Regeneron Pharmaceuticals
ATC code J06

Click the tags to see associated articles and topics

View Article Details
FDA Revokes EUAs of Four COVID-19 Monoclonal Antibodies | MedPage Today

Added to Collection on: 2024-12-13 23:04:03

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Antiviral drugs
Casirivimab/imdevimab
Immune system
Tixagevimab/cilgavimab
Sotrovimab
Bebtelovimab
Regeneron Pharmaceuticals
ATC code J06

Click the tags to see associated articles and topics

View Article Details
Regeneron settles patent lawsuit over protein for testing COVID-19 treatments - TradingView

Added to Collection on: 2024-12-16 20:34:57

Tags for this article:

Monoclonal antibodies
Regeneron Pharmaceuticals
Casirivimab/imdevimab
Pfizer
COVID-19 vaccine
Pharmaceutical industry in India
Patent infringement
George Yancopoulos
Evolocumab
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Invivyd Submits Updated Immunobridging Data To FDA For PEMGARDA EUA Amendment

Added to Collection on: 2025-01-27 18:00:11

Tags for this article:

COVID-19 drug development
Pre-exposure prophylaxis
Treatment and management of COVID-19
Pemivibart
Food and Drug Administration
Emergency use authorization
Antiviral drug
Casirivimab/imdevimab
Bamlanivimab/etesevimab
Invivyd Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Ronapreve - opinion on variation to marketing authorisation - European Medicines Agency

Added to Collection on: 2025-01-31 18:20:56

Tags for this article:

COVID-19 drug development
Monoclonal antibodies
Casirivimab/imdevimab
Committee for Medicinal Products for Human Use
COVID-19
Marketing authorisation
Roche Registration GmbH

Click the tags to see associated articles and topics

View Article Details
Linvoseltamab in Combination with Carfilzomib or Bortezomib Shows Promising Initial ...

Added to Collection on: 2025-05-23 20:43:53

Tags for this article:

Orphan drugs
Multiple myeloma
Carfilzomib
Regeneron Pharmaceuticals
Casirivimab/imdevimab
Checkpoint inhibitor
Isatuximab
Filanesib
Bortezomib
United States

Click the tags to see associated articles and topics

View Article Details
Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with ...

Added to Collection on: 2025-09-22 04:59:28

Tags for this article:

Sanofi
Monoclonal antibodies
Chronic lower respiratory diseases
Anti-asthmatic agents
CAC 40
Dupilumab
Regeneron Pharmaceuticals
Atopic dermatitis
Prurigo nodularis
Eosinophilic esophagitis
Asthma
Casirivimab/imdevimab
REGENERON GENETICS CENTER

Click the tags to see associated articles and topics

View Article Details
Book a Demo